Santarus retreats; drug indexes edge higher
September 10, 2010 at 10:39 AM EDT
Shares of Santarus slip in early trading, a day after they soared on news that the company planned to begin shipping its new diabetes drug in November.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.